Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:35 UTC |
---|
HMDB ID | HMDB0014361 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Eletriptan |
---|
Description | Eletriptan is only found in individuals that have used or taken this drug. It is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches. [Wikipedia ]Eletriptan binds with high affinity to 5-HT1B, 5-HT1D and 5-HT1F receptors, has modest affinity for 5-HT1A, 5-HT1E, 5-HT2B and 5-HT7 receptors, and little or no affinity for 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, 5-HT5A and 5-HT6 receptors. Eletriptan has no significant affinity or pharmacological activity at adrenergic alpha1, alpha2, or beta; dopaminergic D1 or D2; muscarinic; or opioid receptors. Two theories have been proposed to explain the efficacy of 5-HT receptor agonists in migraine. One theory suggests that activation of 5-HT1 receptors located on intracranial blood vessels, including those on the arteriovenous anastomoses, leads to vasoconstriction, which is correlated with the relief of migraine headache. The other hypothesis suggests that activation of 5-HT1 receptors on sensory nerve endings in the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. |
---|
Structure | CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2 InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Eletriptanum | ChEBI | 3-(1-Methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide | HMDB | Eletriptan hydrobromide | HMDB | Relpax | HMDB | (R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole | HMDB | (R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide | HMDB |
|
---|
Chemical Formula | C22H26N2O2S |
---|
Average Molecular Weight | 382.519 |
---|
Monoisotopic Molecular Weight | 382.171498776 |
---|
IUPAC Name | 5-[2-(benzenesulfonyl)ethyl]-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole |
---|
Traditional Name | eletriptan |
---|
CAS Registry Number | 143322-58-1 |
---|
SMILES | CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2 |
---|
InChI Identifier | InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1 |
---|
InChI Key | PWVXXGRKLHYWKM-LJQANCHMSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indoles |
---|
Direct Parent | 3-alkylindoles |
---|
Alternative Parents | |
---|
Substituents | - 3-alkylindole
- Benzenesulfonyl group
- Aralkylamine
- Monocyclic benzene moiety
- Substituted pyrrole
- N-alkylpyrrolidine
- Benzenoid
- Pyrrole
- Pyrrolidine
- Sulfone
- Sulfonyl
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organonitrogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Amine
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organosulfur compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0012 g/L | Not Available | LogP | 3.9 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Eletriptan,1TMS,isomer #1 | CN1CCC[C@@H]1CC1=CN([Si](C)(C)C)C2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C12 | 3381.9 | Semi standard non polar | 33892256 | Eletriptan,1TMS,isomer #1 | CN1CCC[C@@H]1CC1=CN([Si](C)(C)C)C2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C12 | 2997.5 | Standard non polar | 33892256 | Eletriptan,1TMS,isomer #1 | CN1CCC[C@@H]1CC1=CN([Si](C)(C)C)C2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C12 | 4087.5 | Standard polar | 33892256 | Eletriptan,1TBDMS,isomer #1 | CN1CCC[C@@H]1CC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C12 | 3583.7 | Semi standard non polar | 33892256 | Eletriptan,1TBDMS,isomer #1 | CN1CCC[C@@H]1CC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C12 | 3211.8 | Standard non polar | 33892256 | Eletriptan,1TBDMS,isomer #1 | CN1CCC[C@@H]1CC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C12 | 4143.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Eletriptan GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9110000000-bef75cdb82e945554b4a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Eletriptan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 10V, Positive-QTOF | splash10-001i-0309000000-94ede4ac3c6cb8f733c9 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 20V, Positive-QTOF | splash10-001l-9468000000-0e675066db2cea9eb278 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 40V, Positive-QTOF | splash10-0fr6-9401000000-6ea64b3711b1e3449174 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 10V, Negative-QTOF | splash10-001i-0309000000-bca3b55d287b0f646ca0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 20V, Negative-QTOF | splash10-000x-2957000000-13868d17d46c97bfd478 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 40V, Negative-QTOF | splash10-0006-9820000000-93669003e8f047d1c3d6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 10V, Positive-QTOF | splash10-001i-0009000000-bb20fd58f55dd639bd4e | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 20V, Positive-QTOF | splash10-001i-1149000000-398bda48e8642076254a | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 40V, Positive-QTOF | splash10-004i-9311000000-a970ee8f51934ad7a8cb | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 10V, Negative-QTOF | splash10-001i-0009000000-f00e87020d8b2372d4de | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 20V, Negative-QTOF | splash10-001i-0549000000-bd448dd0cb94ea9bb8e6 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Eletriptan 40V, Negative-QTOF | splash10-01ox-4819000000-4c9bae15e3bf79d5fdf9 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|